首页> 外国专利> A RATIO BETWEEN PLGF AND SFLT1 IS PREDICTIVE FOR NEURAL INVASION IN PATIENTS SUFFERING FROM PANCREATIC CANCER

A RATIO BETWEEN PLGF AND SFLT1 IS PREDICTIVE FOR NEURAL INVASION IN PATIENTS SUFFERING FROM PANCREATIC CANCER

机译:PLGF和SFLT1之间的比率是患有胰腺癌患者的神经侵袭的预测性

摘要

The present invention is directed to a method for identifying neural invasion in a pancreatic cancer patient, the method comprising the steps of: determining in a sample of a pancreatic cancer patient the expression level of PIGF and sFlt1; and calculating a ratio of the expression levels of PIGF and sFlt1, wherein the expression level of PIGF forms part either of the numerator or of the denominator of the ratio; characterized in that, a deviation of the ratio of the patient sample from a reference sample or a predetermined threshold value is indicative for presence of neural invasion of the pancreatic cancer in said patient. Preferably said deviation, when the ratio is expressed using the expression level of PIGF in the numerator, is an increase in the ratio of the patient sample compared to a reference sample or a predetermined threshold value and/or said deviation, when the ratio is expressed using the expression level of PIGF in the denominator, is a decrease in the ratio of the patient sample compared to a reference sample or a predetermined threshold value.
机译:本发明涉及鉴定胰腺癌患者中神经侵袭的方法,该方法包括以下步骤:确定在胰腺癌患者样本中的猪肉和SFLT1的表达水平;并计算猪和SFLT1的表达水平的比例,其中猪猪的表达水平形成分数的部分或比例的分母;其特征在于,患者样品与参考样品或预定阈值的比率的偏差是指在所述患者中存在胰腺癌的神经侵袭。优选地,当使用分子中的猪猪的表达水平表达比率时,与参考样品或预定阈值和/或所述偏差表示该比率时,患者样品的比例的增加使用仔猪在分母中的表达水平,与参考样品或预定阈值相比,患者样品的比例的降低。

著录项

  • 公开/公告号EP3936868A1

    专利类型

  • 公开/公告日2022-01-12

    原文格式PDF

  • 申请/专利权人 CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN;

    申请/专利号EP20200185174

  • 发明设计人 FISCHER CHRISTIAN;

    申请日2020-07-10

  • 分类号G01N33/574;A61K39;C07K16;

  • 国家 EP

  • 入库时间 2022-08-24 23:19:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号